Anita Laxova

发表

Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis.

Ryan J Coller, J. Eickhoff, P. Farrell, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.

M. Kosorok, P. Farrell, J. Collins, 2003, American journal of respiratory and critical care medicine.

Cystic Fibrosis Newborn Screening: Impact on Reproductive Behavior and Implications for Genetic Counseling

P M Farrell, B. Wilfond, P. Farrell, 1998, Pediatrics.

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

M. Kosorok, R. Laessig, P. Farrell, 2001, Pediatrics.

Clarification of Laboratory and Clinical Variables That Influence Cystic Fibrosis Newborn Screening With Initial Analysis of Immunoreactive Trypsinogen

P. Farrell, W. Gershan, Zhanhai Li, 2009, Pediatrics.

Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!

M. Kosorok, R. Laessig, P. Farrell, 2005, The Journal of pediatrics.

Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.

M. Kosorok, R. Koscik, P. Farrell, 2004, Pediatrics.

Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols.

B. Wilfond, P. Farrell, E. Mischler, 1993, American journal of human genetics.

Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

M. Kosorok, P. Farrell, E. Mischler, 1997, The New England journal of medicine.

Genetic Counseling and Neonatal Screening for Cystic Fibrosis: An Assessment of the Communication Process

P. Farrell, A. Laxova, L. Rock, 2001, Pediatrics.

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.

M. Kosorok, R. Laessig, R. Koscik, 1997, Pediatrics.

Delayed diagnosis of US females with cystic fibrosis.

M. Kosorok, P. Farrell, A. Laxova, 2002, American journal of epidemiology.

Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.

M. Kosorok, L. S. Broderick, P. Farrell, 2009, Radiology.

Reproducibility of a Scoring System for Computed Tomography Scanning in Cystic Fibrosis

Michael R Kosorok, M. Kosorok, L. S. Broderick, 2006, Journal of thoracic imaging.

Proteomic Identification of OprL as a Seromarker for Initial Diagnosis of Pseudomonas aeruginosa Infection of Patients with Cystic Fibrosis

A. Rao, P. Farrell, J. Barbieri, 2009, Journal of Clinical Microbiology.

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

M. Kosorok, P. Farrell, J. Collins, 2005, JAMA.

Early Immune Response to the Components of the Type III System of Pseudomonas aeruginosa in Children with Cystic Fibrosis

M. Kosorok, J. Moss, P. Farrell, 2005, Journal of Clinical Microbiology.

Nutritional assessment of infants with cystic fibrosis diagnosed through screening

P. Farrell, E. Mischler, A. Laxova, 1991, Pediatric pulmonology. Supplement.

Refining the continuum of CFTR‐associated disorders in the era of newborn screening

S. McColley, P. Farrell, M. Nugent, 2016, Clinical genetics.

Applying whole-genome sequencing in relation to phenotype and outcomes in siblings with cystic fibrosis

J. Holt, E. Worthey, M. Wilk, 2020, Cold Spring Harbor molecular case studies.

Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis

P. Farrell, J. Collins, Zhanhai Li, 2003, Pediatric pulmonology.

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

M. Kosorok, P. Farrell, J. Collins, 2001, Pediatric pulmonology.

Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.

M. Kosorok, P. Farrell, S. E. West, 2002, JAMA.

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

M. Kosorok, M. Rosenberg, C. Férec, 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

A. Grieve, T. Becker, P. Farrell, 2013, Journal of developmental and behavioral pediatrics : JDBP.

Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis

P. Farrell, A. Laxova, M. Rock, 1998, Pediatric pulmonology.

Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.

E. Mischler, M. Kosorok, Mark Splaingard, 1997, Pediatrics.

Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention.

P. Farrell, E. Mischler, A. Laxova, 1991, The American journal of clinical nutrition.

Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.

M. Kosorok, R. Koscik, P. Farrell, 2005, The Journal of pediatrics.

Wisconsin cystic fibrosis chest radiograph scoring system: Validation and standardization for application to longitudinal studies

J. Gurney, P. Farrell, J. Collins, 2000, Pediatric pulmonology.